Sign in

NCT05652868CompletedPhase 1/2

Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 May 2025

Status (registry)
Completed
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
60 (actual)
First submitted
17 Oct 2023
Start date
19 Apr 2024
Lead sponsor
Mythic Therapeutics Inc.
Diseases
Lung cancer
NCT number
NCT05652868
EU CT number
2023-504630-22-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Participants enrolled: 60
  • 16 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (16)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hospital HM Nou Delfos
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Instituto Oncologico Dr. Rosell S.L.
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitario HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Quironsalud Malaga
Coordinator of this site? Confirm its status
MálagaSpainCompleted
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Coordinator of this site? Confirm its status
ValenciaSpainCompleted
Hospital Clinico Universitario Lozano Blesa
Coordinator of this site? Confirm its status
ZaragozaSpainCompleted
Institut Bergonie
Coordinator of this site? Confirm its status
BordeauxFranceCompleted
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceCompleted
Assistance Publique Hôpitaux de Marseille
Coordinator of this site? Confirm its status
MarseilleFranceCompleted
Institut Curie
Coordinator of this site? Confirm its status
ParisFranceCompleted
Institut De Cancerologie De L Ouest
Coordinator of this site? Confirm its status
St HerblainFranceCompleted
Institut Universitaire Du Cancer Toulouse-Oncopole
Coordinator of this site? Confirm its status
Toulouse Cedex 9FranceCompleted
Institut Gustave Roussy
Coordinator of this site? Confirm its status
Villejuif CedexFranceCompleted

This page is information, not medical advice. Discuss any trial with your doctor.